About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pharmadrug Inc (OP: LMLLF )

0.0169 +0.0043 (+34.13%)
Streaming Delayed Price Updated: 9:59 AM EST, Nov 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pharmadrug Inc

< Previous 1 2 3 4 5 6 7 Next >
Cannabis Stock Gainers And Losers From July 18, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From July 11, 2023
Via Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and... 
Via Benzinga
Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind
Specialty R&D psychedelics company PharmaDrug Inc. (OTCQB: LMLLF) has inked a research collaboration agreement with PharmaTher Holdings Ltd. (OTCMKTS: PHRRF) to evaluate the delivery of DMT through... 
Via Benzinga
Khiron Completes Acquisition Of Pharmadrug Production, Expanding Its Presence In Europe
Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt:A2JMZC) has completed the acquisition of Pharmadrug Production GmbH from Pharmadrug Inc. (OTCQB: LMLLF) (CSE:PHRX). 
Via Benzinga
Khiron To Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer And Wholesaler
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt: A2JMZC), has entered into an agreement to acquire Pharmadrug GmbH from its parent PharmaDrug Inc. (CSE:PHRX) (OTCQB: LMLLF). 
Via Benzinga
Cannabis Movers & Shakers: TrueGreen, PSYC, BioSteel Sports Nutrition, Perfect Union, YourWay Cannabis Brands
Via Benzinga
PharmaDrug Advances DMT-Analogue Program For Glaucoma
PharmaDrug Inc. (OTCQB: LMLLF) (CSE: PHRX) in collaboration with the Terasaki Institute for Biomedical Innovation, has successfully completed the fabrication of a novel medical device capable of... 
Via Benzinga
PharmaDrug Posts Positive Results For DMT-Analogue Program To Treat Glaucoma
Psychedelics and cannabis-focused pharmaceutical company PharmaDrug Inc. (CSE: 
Via Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Contents 
Via Benzinga
PharmaDrug Strikes Deal With Johns Hopkins University For A Clinical Trial Into Psychedelic DMT
On Wednesday, PharmaDrug Inc. (CSE:PHRX) (OTC: 
Via Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
The Week In Psychedelics 
Via Benzinga
Bearish Sentiment Toward Market: Cannabis Movers For July 19, 2021
GAINERS: Livewell Canada Inc (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
Australis, CV Sciences And MedMen Among Top Cannabis Stock Movers On July 9, 2021
GAINERS: Livewell Canada Inc (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray, KushCo And Aurora Among Top Cannabis Stock Movers On June 28, 2021
GAINERS: Mexco Energy (AMEX: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psyched: MindMed's Nasdaq Debut, PharmaDrug Gets Orphan Drug Designation For DMT, Numinus Launches Clinical Trial Of Naturally Derived Psilocybin
PharmaDrug Inc. (CSE:BUZZ) (OTC: 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.